By incorporating non-invasive indicators such as age, Hb, and RDW-CV, this model effectively assesses tumor progression and pathological type during initial clinical diagnosis, thereby reducing the frequency of invasive examinations. The gene discussed is GSTM1; the disease is neoplasm.